MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS)
Clinical trials for MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS) explained in plain language.
Never miss a new study
Get alerted when new MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS) trials appear
Sign up with your email to follow new studies for MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a drug nip myeloma in the bud? new trial aims to stop cancer before it starts
Disease control Recruiting nowThis Phase 2 trial is testing an investigational drug called linvoseltamab in 116 people with precancerous blood conditions that raise their risk of developing multiple myeloma. The goal is to see if the drug can eliminate abnormal plasma cells and lab signs of disease. Researche…
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS)
Phase: PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 23, 2026 11:57 UTC
-
Simple blood test could catch myeloma years earlier in High-Risk groups
Diagnosis Recruiting nowThis study aims to detect multiple myeloma at its earliest stage, called MGUS, using a simple blood test. It will screen 1,665 Black adults and close relatives of people with plasma cell disorders. The goal is to reduce delayed diagnosis and improve outcomes by catching the disea…
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS)
Sponsor: Wake Forest University Health Sciences • Aim: Diagnosis
Last updated Jun 23, 2026 11:57 UTC
-
Massive study aims to unlock secrets of early blood cancers
Knowledge-focused Recruiting nowThis study looks at genetic changes in people with early-stage blood cancers or conditions that may lead to cancer. Researchers will analyze blood, bone marrow, or cheek cell samples from up to 10,000 participants to find DNA errors linked to cancer risk and progression. The goal…
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS)
Sponsor: Dana-Farber Cancer Institute • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:54 UTC
-
New study aims to predict who will develop multiple myeloma
Knowledge-focused Recruiting nowThis study looks at 60 people with early blood conditions (MGUS or smoldering myeloma) that can sometimes turn into multiple myeloma, a type of blood cancer. Researchers will use advanced genetic and immune system tests to find clues that predict which patients are at higher risk…
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS)
Sponsor: Azienda USL Reggio Emilia - IRCCS • Aim: Knowledge-focused
Last updated Jun 11, 2026 11:57 UTC